IV Poland Pharma Commerce Forum

Transcription

1 IV Poland Pharma Commerce Forum A JOINT OPINION OF THE PHARMACEUTICAL INDUSTRY ON THE MOST STRATEGIC ISSUES! AMONG INSPIRATORS: Mathieu Fitoussi General Manager SERVIER Krzysztof Kozik General Manager NOVO NORDISK PHARMA Bogdan Lang USP LIFE SCIENCES Sławomir Chomik former General Manager ABBOTT LABORATORIES Bartosz Bednarz ASTRAZENECA PHARMA Michał Nitka Director General, TEVA PHARMACEUTICALS Izabela Zimmermann Director General, Vice- ACTAVIS Marta Wielondek Country Manager BAUSCH+LOMB Jerzy Wasilewski, Director General WALMARK Paweł Sztwiertnia Director General INFARMA Irena Rej President THE FARMACJA POLSKA CHAMBER OF COMMERCE Andrzej Ryszard Stachnik ZPHF Ewa Jankowska President PASMI Director of Regulatory USP ZDROWIE Michał Pilkiewicz Country Manager IMS HEALTH Piotr Kula President PHARMAEXPERT Dariusz Nowicki Director PIPFiWM POLFARMED O R G A N I Z E R:

2 IV Poland Pharma Commerce Forum Introduction: Ladies and Gentlemen! Similar to previous years we would like to invite You to a strategic dialogue among Presidents, Board Members, Directors and Managers, as we believe, and it has been proven, that an open discussion a meeting of the most important decision-makers of the whole industry, can make the pharmaceutical industry in Poland change for better. Even though You still call for the uncertain market situation after the 2012 revolution, I do sense some slight optimism regarding the year It is supposed to be a year of stabilisation, hardening and getting ready for the It will be about looking for innovative, more adequate strategies, tactics and solutions, developing new areas of business and tools which will reflect even better the new needs of our evolving Clients: doctors, pharmacists, patients the most important challenges in front of us You talk about! The annual, strategic meeting of all the players of the pharmaceutical market is a unique opportunity for You to share in Your own society of expert-practitioners the experience and plans, to inspire one another for innovative actions, to compare Your strategies in terms of the future business development. You are a part of the pharmaceutical industry, so You cannot miss it! Aleksandra Schoen-Żmijowa - Project Director Why it is worth to join us: Phone: aleksandra.schoen@bluebusinessmedia.com Being authentic, open and ready to share is the only way to really improve the situation of the whole sector as well as the situation of Your company! The well-proven formula of the Forum Practitioners to Practitioners ; the inspiration provided by 24 Presidents, Directors-General and sector experts, representing among others: AstraZeneca Pharma, Servier, Teva Pharmaceuticals, Actavis, Walmark, Bausch+Lomb, USP Zdrowie, Abbott Laboratories, Novo Nordisk Pharma. Issues identified during a detailed research to be discussed together, to be the subject of an exchange of knowledge and well-tested solutions and experience, constitute the unique value of the meeting! Henry Ford, the founder of General Motors once said: Coming together is a beginning; keeping together is progress; working together is success, and therefore, we are going to do our best to facilitate Your meeting of the VIPs of the sector! The dialog participants: 7% 5% CEO, General Director, Board Member Sales & Marketing Director, Business Unit Director Category, Product, Brand Manager Other 36% 52 % Blue Business Media with Sapphire Ventures and Centrum EXPO XXI are part of Sapphire Group, the organizer of professional industry and consumer fairs and events in ConfEx formula (fair and conference). We are part of:

3 Day I 13 June 2013, Thursday AGENDA Chairman: Mariusz Borkowski, Marketing Manager, Adamed 9:30 Registration and morning coffee 10:00 10:20 Main Rx and OTC trends Reimbursement and patient surcharges Drug availability Situation in the distribution chain Market forecasts 10:50 Interactive question and answer session 11:00 Discussion with presentations before: 11:50 Coffee break 12:10 Opening of the Forum and the networking session Casper Haring, Managing Director, BLUE BUSINESS MEDIA Please, use this networking session in order to identify straight away who participates in the meeting. Open Your mind to this mutual inspiration and the exchange of experience. PHARMA 2013 MARKET OVERVIEW AND TRENDS The Polish pharmaceutical market a year after the legal revolution Piotr Kula, President, PHARMAEXPERT A fruitful collaboration. The most difficult challenges and expectations by all the groups active in the pharmaceutical market: pharmacies, wholesalers, OTC and Rx producers, doctors and patients Ewa Jankowska,, PASMI, Director of Regulatory and Medical Affairs, USP ZDROWIE Irena Rej, President, THE FARMACJA POLSKA CHAMBER OF COMMERCE Michał Nedoszytko, Founder, PORTAL BARTOSZMOWI.PL Dariusz Nowicki, Director, PIPFIWM POLFARMED Andrzej Ryszard Stachnik, President, ZWIĄZEK PRACODAWCÓW HURTOWNI FARMACEUTYCZNYCH Paweł Sztwiertnia, General Director, INFARMA STRATEGIC PERFORMANCE IN PHARMA Pharmaceutical management in a new era: change, optimization and transformation lead to different roles Mathieu Fitoussi, General Manager, SERVIER New era, what does it mean? Different stakeholders, different need, organisation, communication and tools What impact for managers and management 12:40 Interactive question and answer session 12:50 Sławomir Chomik, former General Manager, ABBOTT LABORATORIES Expectations by stakeholders are we speaking the same language? Different strategies the patient is still in the centre Ethics when doing business indispensible success factor 13:20 Interactive question and answer session 13:30 Lunch 14:30 Performance at the time of crisis Marta Wielondek, Country Manager, BAUSCH+LOMB Crisis dynamics Internal vs. external risk factors Corporate health 15:00 Interactive question and answer session 15:10 Coffee break and selecting one of the topic groups 15:30 16:40 Break to move to another group 17:55 Redefining the business model is necessary predictability is the key INTERACTIVE TOPIC GROUPS Please, join us for discussion meetings in smaller groups. The aim of the meetings is to get concrete and ready to implement knowledge and inspiration concerning selected and the most interesting areas of Your professional and personal development. There will be two rounds of each meeting Interactive topic groups part I New approach towards compensation systems the way changes to the market affect any modification of the existing approach Michał Pilkiewicz, Country Manager, IMS HEALTH Szymon Komorowski, Consulting Team Manager, IMS HEALTH Critical aspects of the Rx products sales forecasting Stefan Bogusławski,, SEQUENCE HC PARTNERS Anna Smaga, Senior Partner and the Vice-President of the Board, SEQUENCE HC PARTNERS Becoming successful in a crisis about the leadership at the time of changes, restructuring and cost cuts Anna Dobieszewska, Founder, INTEGRITY Saving one hour every day and still managing to do everything on time. Practical solutions to be used in your everyday work RIGHT AWAY Bartłomiej Sołowiej, CEO, PEP -IBT Poland 16:45 Interactive topic groups part II NETWORKING KOKTAJL an excellent opportunity to integrate even more 19:45 The end of the first day of the Forum

4 Day II 14 June 2013, Friday Chairman: Mariusz Borkowski, Marketing Manager, Adamed 9:00 Registration and morning coffee 9:30 9:45 Strategic panel discussion: Implications of market changes to the business models of the Rx and OTC pharmaceutical companies Moderator: Michał Pilkiewicz, Country Manager, IMS HEALTH Izabela Zimmermann, General Director, ACTAVIS Bartosz Bednarz, CEO, ASTRAZENECA PHARMA Michał Nitka, General Director, CEO, TEVA PHARMACEUTICALS Jerzy Wasilewski, General Director, CEO, WALMARK 10:25 Panel discussion: Investing in innovation at the time of crisis tools which really support the business (owe are expecting a confirmation from our Panellists) 10:55 Coffee break THE NEW POLAND PHARMA: FUTURE DEVELOPMENT POTENTIAL The most efficient business model an analysis of companies active in the CEE region Michał Pilkiewicz, Country Manager, IMS HEALTH THE MOST SERIOUS CHALLENGE: ACCESS TO MODERN DRUGS 11:15 The role of the Risk Sharing Scheme tools (RSS) in enabling patients access to modern medical technologies (modern drugs) Bartosz Bednarz, CEO, ASTRAZENECA PHARMA Aldona Zygmunt, External Relation Director, ASTRAZENECA PHARMA Does the Payer use the legislative tools (to what extend) to enable the sharing of risk of modern drugs reimbursement Risk Sharing Scheme tools in the dialogue with the Payer to satisfy the society health protection needs The optimum shape of the RSS mechanisms the efficiency of the medical technology in terms of the expected therapeutic effects 11:45 Interactive question and answer session 11:55 Strategic panel discussion: How about the innovation patients are going to ask for modern drugs! What can we do in order to introduce new drugs to the market more efficiently? Łukasz Kaczmarek, Professor, Director, THE PHARMACEUTICAL INSTITUTE Krzysztof Kozik, General Director, NOVO NORDISK PHARMA Dr n.med. Bogdan Lang, General Director, USP LIFE SCIENCES 12:35 Lunch 13:35 The value of patients purchasing basket changed by the introduction of the Reimbursement Act Stefan Bogusławski, Managing Partner, CEO, SEQUENCE HC PARTNERS Different prescribed drugs purchased by patients Patients purchasing baskets by age and type of illness Types of baskets main trends 14:05 Interactive question and answer session 14:15 Self-medication as a sphere of the pharmaceutical industry to be developed Ewa Jankowska,, PASMI, Director of Regulatory and Medical Affairs, USP ZDROWIE Self-medication vs. the public health Economic aspects of the self-medication The contemporary Polish patient, what affects the self-medication and what are patient s needs 14:45 Interactive question and answer session 14:55 Coffee break 15:10 Customer Centric Organization the patientcentric perspective in promotional and sales strategies Jerzy Wasilewski, General Director, CEO, WALMARK Identifying consumers needs Responding to customer s needs using the insights collected What can we do with them? 15:40 Interactive question and answer session 15:50 PATIENT IN THE CENTRE OF THE COMPANY ATTENTION INTERACTIVE LEGAL SESSION The legal changes planned for 2013/2014 and their implications for the functioning of the pharmaceutical industry We are expecting a confirmation from the Speaker About the reimbursement act implications of changes to Rx and OTC The interpretation of medicinal products and dietary supplements in advertising The protection of personal data in pharmacy 16:40 Open discussion of all the participants to sum up: Beyond barriers collaborating even better 17:00 A free ticket to the next edition of the event! Lottery among all the present in the room 17:10 The end of the Forum and certificates

5 Experiences and inspirations: Mathieu Fitoussi General Manager, SERVIER A master of management. He has huge experience as a Country Manager (gathered in Slovenia, Morocco and Poland). He was responsible for developing the company activities in the Baltic States and Slovenia. He coordinated projects dealing with representative offices in the UK and Germany. He had started at MSD in France. Sławomir Chomik former General Manager, ABBOTT LABORATORIES He started his professional career in 1993 as a medical representative at Solvay Pharmaceuticals. Then, he proceeded to the company Central Office in Hannover, among others, where he occupied the position of the Medical & Marketing Manager for Eastern Europe and the Global Product Director. In 2006 he became the Area Director for EU and later got promoted to become the Area Director of CIS Region. Krzysztof Kozik Director General, NOVO NORDISK PHARMA He has huge experience in developing and implementing the company development strategy. In the pharmaceutical industry since 1999, in Novo Nordisk. He was the Financial Director in France and Belgium as of 2009 and then, in 2012 he became the Director General at Novo Nordisk in Poland. Michał Nitka Director General,, TEVA PHARMACEUTICALS, the Supervisory Board Member, PZPPF Working for the pharmaceutical industry for 17 years. He has occupied key positions in leading pharmaceutical companies of both the innovative and generic sector. In 2010 he was awarded the honorary title of the Managing LEADER by Gazeta Farmaceutyczna monthly magazine. Izabela Zimmermann Director General and Vice-, ACTAVIS The Director General and the Vice- of Actavis Polska since the company is the fourth biggest corporation producing generic drugs in the world. For several years has she been working for the pharmaceutical industry in Poland. She has occupied key managerial positions in marketing management and the sales of generic drugs. Bartosz Bednarz resident of the Board, ASTRAZENECA PHARMA His professional career started in 1996 in Novartis Poland, where he was responsible for marketing and sales. Then, he moved to Novartis Pharma AG, Novartis in Canada and Novartis in Spain. He returned to Poland as the Marketing Director and started working as the Director General of Novartis Onkologia in September Jerzy Wasilewski, Director General, WALMARK He has been in the sales management, trade marketing, category management and FMCG products marketing businesses for 16 years. In August 2010 he joined the pharmaceutical industry to become the of the second biggest company in the market of dietary supplements and the OTC products. For the last few years he has been involved in the development and then the successful implementation of company strategies. Paweł Sztwiertnia Director General of the Employers Union of Innovative Pharmaceutical Companies, INFARMA I am an expert in the arrangement and the funding of healthcare and a specialist in the public health matters. He used to be a deputy health minister and the deputy Director of the Budget Zone Financing Department at the Ministry of Finance. He used to be a member of the Board of the National Health Fund (NFZ). Łukasz Kaczmarek Assistant Professor, Director, THE PHARMACEUTICAL INSTITUTE Heading 12 research projects funded by the State Committee for Scientific Research (KBN) of the Technological Initiative, originating in the Operational Programme Innovative Economy, the National Centre for Research and Development ( NCBiR), the Servier company and the Foundation for Polish Science. He is the author or the coauthor of 16 technological publications, including 12 implementations of generic substances technologies, as well as over 110 scientific publications and over 50 patents or patent applications. Andrzej Ryszard Stachnik, THE ASSOCIATION OF POLISH PHARMACEUTICAL WHOLESALERS EMPLOYERS Working for the Polish pharmaceutical industry for over 20 years. He was one of the founders of the ACP Pharma Capital Group. At present he occupies the post of the Board Member and the Sales Director and has been responsible for the sales policy of the SymPhar pharmaceutical company. He has been engaged in the local government activities for the whole pharmaceutical society. Bartłomiej Sołowiej Chief Operations Officer, PEP -IBT POLAND In the international pharmaceutical business for 17 years. Responsible for managing large teams of people. As the Business Unit Manager he has managed the preparatory stage and the very introduction of highly specialised medicinal products to the market. At present he has been involved in providing unique solutions to improve work and everyday actions efficiency. Marta Wielondek Country Manager, BAUSCH+LOMB Bogdan Lang PhD,, USP LIFE SCIENCES He is responsible for the market success of the US Pharmacia (APAP, Ibuprom, Gripex, Vigor, etc.). The Director General and the of the USP Group since its very beginning in Since 2010 he has been the President of the USP Life Sciences company, that deals with innovative biomedicine projects. Irena Rej President, THE FARMACJA POLSKA CHAMBER OF COMMERCE She has been managing a sector organisation that gathers over 100 business entities, active in the pharmaceutical industry for 18 uninterrupted years. The organisation gathers producers, distributors and importers of medicinal products. She is the owner of DAGOMED Pharma, producing homeopathic drugs and the SARAMED pharmaceutical wholesale outlet. Ewa Jankowska, PASMI Director of Regulatory and Medical Affairs, USP ZDROWIE She specialises in all the matters relating to the research, development and the registration of medical products and medical information. She is experienced in the OTC drugs, dietary supplements and medicinal products, introducing them, labelling and advertising. Michał Nedoszytko Founder, PORTAL BARTOSZMOWI.PL He introduced the bartoszmowi.pl web browser for reimbursed drugs at the beginning of Every third doctor in Poland now uses this internet tool and its popularity spread at a skyrocketing pace during the first days of its functioning only, as if it was a computer virus. He is a cardiologist at the Interventional Cardiologic Unit of the hospital in Wejherowo. Michał Pilkiewicz Country Manager, IMS HEALTH He has over 20-year professional experience. At the beginning he worked for distribution companies of the ORFE Group, where the ACP Pharma was created. Then, he worked for IMS Health and occupied the position of the Sales Director, he was the acting Director General and then while still being the Sales Director he became responsible for 19 countries of the Central and Eastern European region. He was also the President of the Board of Enovatis. Aldona Zygmunt Director of External Affairs, ASTRAZENECA PHARMA She was responsible for preparing and conducting the negotiation process for the reimbursed drugs by AZ covered by the Reimbursement Act of She has been in the pharmaceutical business since 1993, since 2010 in AstraZeneca, with huge experience in projects aiming at the development of a communication platform, to be used by public administration institutions and non-government organisations. Stefan Bogusławski Managing Partner, SEQUENCE HC PARTNERS An expert of the pharmaceutical market in Poland and the Vice-President of the Polish Centre of Medical Statistics. He got his professional experience in IMS Health (Regional Manager Central Europe, Country Manager Poland). He is the author of many articles relating to the healthcare matters. Dariusz Nowicki Director, The Polish Chamber of Pharmaceutical Industry of Pharmaceutical Products POLFARMED In the pharmaceutical industry and the drug market for over 17 years. He got his experience in various pharmaceutical companies, the National Association of Sickness Funds and the Polish Chamber of Pharmaceutical Industry and Pharmaceutical Products Polfarmed. Piotr Kula President, PHARMAEXPERT He is a doctor by education and a businessman by vocation, for many years has been professionally and emotionally attached to the pharmaceutical sector. He has been dealing with the pharmaceutical market research and the strategic and tactic consulting for a number of entities, active in the healthcare industry. Anna Smaga Senior Partner and the Vice- SEQUENCE HC PARTNERS Od lat specjalizuje się w badaniach rynku oraz doradztwie w ochronie zdrowia. Zajmuje się m.in. prognozowaniem rynku farmaceutycznego w zakresie modeli epidemiologicznych, prognoz sprzedaży, finansowania terapii przez płatników oraz zagadnieniach kształtowania cen. Anna Dobieszewska Founder, INTEGRITY For 10 years in managerial positions of the human resources management area. As the Director of the Department of Training and Development of Polska Telefonia Cyfrowa, the T-Mobile operator, she was responsible for the implementation of the company HR development programmes and the organisational culture development programmes. She is a coach certified by the International Coaching Community (ICC) and the Erickson College International. Szymon Komorowski Manager of the Consulting Team, IMS HEALTH In over 40 consulting projects which relate to, among others: restructuring of the sales function and determining the structure and the size of medical teams. He joined the IMS in He used to work in the strategic consulting team in Deloitte.

6 ON THE STRATEGIC FORUM OF THE POLISH PHARMACEUTICAL INDUSTRY The top players of the Polish pharmaceutical market still talk to each other too little. They do not share their experience often enough, especially in the face of all the huge changes resulting from the new reimbursement act, introduced last year. The Poland Pharma Commerce Forum is an excellent opportunity to understand each other better and the develop mutual strategies. Krzysztof Skup, Director General, Egis This meeting gives you this unique opportunity to participate in panel discussions but also to confront your own opinions and strategies with those of other top managers. One sentence or a presentation may be sometimes enough to change our point of view or to help us adjust our companies better to the new market environment. Michał Pilkiewicz, Country Manager, IMS Health Apply today! Only until April 26, 2013 you can save Only until May 17, 2013 you can save 1000 PLN 500 PLN We know more than one person from a company may attend our events. In order to meet your needs better, we would like to offer special application conditions if more than one employee of one company applies. DO YOU WANT TO SHARE YOUR KNOWLEDGE AND TOOLS? Anna Chrobot B4B Communications Manager tel.: anna.chrobot@bluebusinessmedia.com DO YOU WANT TO JOIN? Anna Banaś Head of Sales tel.: anna.banas@bluebusinessmedia.com PARTNERS: EXHIBITOR PATRONS: MEDIA PATRON